C - Chemistry – Metallurgy – 12 – Q
Patent
C - Chemistry, Metallurgy
12
Q
C12Q 1/68 (2006.01) G01N 33/574 (2006.01) G01N 33/58 (2006.01)
Patent
CA 2161778
This invention relates to the detection of prostate-specific antigen (PSA) in female breast tumor extract as a prognostic or predictive indicator for breast carcinoma. The presence of prostate-specific antigen in breast tumors is associated with earlier disease stage, younger women and better survival. PSA is associated with tumors which have estrogen and/or progesteron receptors.
Nordion International Inc.
Sim & Mcburney
LandOfFree
Detection of prostate-specific antigen in breast tumors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Detection of prostate-specific antigen in breast tumors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Detection of prostate-specific antigen in breast tumors will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1614152